Pharmacological characterization of the isolated canine prostate

Journal of Urology

Volumn 155, Issue 5, 1996, Pages 1758-1761

  Normandin, Diane E ^a   Lodge, Nicholas J ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

drug effects; prostate

Indexed keywords

2 CYANO 1 (1,1 DIMETHYLPROPYL) 3 (3 PYRIDYL)GUANIDINE; ADENYLATE CYCLASE ACTIVATOR; ADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBACHOL; CROMAKALIM; DIAZOXIDE; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN RECEPTOR ANTAGONIST; FORSKOLIN; HISTAMINE; ISOPRENALINE; METHOXAMINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENYLEPHRINE; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM CHLORIDE; PRAZOSIN; SARAFOTOXIN S6A; SEROTONIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; MALE; MUSCLE FORCE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE RELAXATION; URETHRA OBSTRUCTION;

EID: 0029917951     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66193-7     Document Type: Article

References (23)

1. Berkow, R. (ed): The Merck Manual of Diagnosis and Therapy. Rahway, New Jersey: Merck Research Laboratories, 16th edition, p. 1736, 1992.
2. Caine, M., Raz, S. and Zeigler, M.: Adrenergic and cholinergic receptors in the human prostate, prostatic capsule, and bladder neck. Br. J. Urol., 47: 193, 1975.
3. Lowe, F. C. and Stark, E.: The use of a-blockers in the management of benign prostatic hyperplasia. N.Y. State J. Med., 93: 169, 1993.
4. Junewicz, P. E., Hoekstra, S. J., Lemp, B. M., Barbolt, T. A., Devin, E., Frenette, G., Dube, J. Y. and Trembley, R. R.: Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finesteride (MK-906), a steroidal 5α-reductase inhibitor, on the prostate and testes of beagle dogs. Endocrinology, 133: 904, 1993.
5. McNeal, J. E.: Normal histology of the prostate. Am. J. Surg. Pathol., 12: 619, 1988.
6. Miller, M. E.: Anatomy of the Dog. Philadelphia: W. B. Saunders Co., p. 762, 1964.
7. Ettinger, S. J.: Textbook of Veterinary Internal Medicine. Diseases of the Dog and Cat. Philadelphia: W. B. Saunders Co., p. 1459, 1975.
8. Bartsch, G. and Pohr, H. P.: Comparative light and electron microscopic study of the human, dog, and cat prostate. An approach to an experimental model for human benign prostatic hyperplasia - a review. Urol. Int., 35: 91, 1980.
9. Cohen, M. and Drey, K: Contractile responses in bladder body, bladder neck, and prostate from rat, guinea pig, and cat. J. Pharmacol. Exp. Ther., 248: 1063, 1989.
10. Hedlund, H., Anderson, K.-E. and Larrson, B.: Alpha-adrenoceptors and muscarinic receptors in the isolated human prostate. J. Urol., 134: 1291, 1985.
11. 1 adrenergic receptors in human benign prostatic hyperplasia. J. Urol., 132: 1226, 1984.
12. 1-adrenoceptors: consensus update. Pharmacol. Rev., 47: 267, 1995.
13. Goetz, A. S., Lutz, M. W., Rimele, T. J. and Saussy, D. L.: Characterization of alpha-1 adrenoceptor subtypes in human and canine prostate membranes. J. Pharmacol. Exp. Ther., 271: 1228, 1994.
14. Kobayashi, S., Tang, R., Wang, B., Opgenorth, T., Stein, E., Shapiro, E. and Lepor, H.: Localization of endothelin receptors in the human prostate. J. Urol., 151: 763, 1994.
15. Kobayashi, S., Tang, R., Wang, B., Opgenorth, T., Langenstroer, P., Shapiro, E. and Lepor, H.: Binding and functional properties of endothelin receptor subtypes in the human prostate. Mol. Pharmacol., 45: 306, 1994.
16. Langenstroer, P., Tang, R., Shapiro, E., Divish, B., Opgenorth, T. and Lepor, H.: Endothelin-1 in the human prostate: tissue levels, source of production, and isometric tension studies. J. Urol., 149: 495, 1993.
17. Lepor, H., Gup, D. I. and Bauman, M.: Laboratory assessment of terazosin and α-blockade in prostatic hyperplasia. Urology, 32: 21, 1988.
18. Drescher, P., Eckert, R. E. and Madsen, P. O.: G-proteins in alpha 1-adrenoceptor mediated prostatic smooth muscle contraction. Urol. Res., 22: 143, 1994.
19. Anderson, K-E.: Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol. Rev., 45: 254, 1993.
20. Dunne, M. J., Aspinall, R. J. and Petersen, O. H.: The effects of cromakalim on ATP-sensitive potassium channels in insulin-secreting cells. Br. J. Pharmacol., 99: 169, 1990.
21. Takeda, M., Tang, R., Shapiro, E., Burnett, A. L. and Lepor, H.: Effects of nitric oxide on human and canine prostates. Urology, 45: 440, 1995.
22. Morita, T., Tsujii, T. and Dokita, S.: Regional differences in functional roles of cAMP and cGMP in lower urinary tract smooth muscle contractility. Urol. Int., 49: 191, 1992.
23. Yazawa, H., Saita, Y., Iida, E., Honma, Y., Morita, T. and Honda, K.: Characterization of muscarinic cholinoreceptor in primary culture of smooth muscle cells from human prostate. J. Urol., 152: 2173, 1994.